<?xml version="1.0" encoding="UTF-8"?>
<p>In men with recurrent distant oligometastases, a number of early phase clinical trials (STOMP, ORIOLE, POPSTAR) have demonstrated promise with MDT (either SABR or metastasectomy), mainly with regard to improving ADT-free and early PFS.
 <xref rid="R24" ref-type="bibr">24 55â€“57</xref> The impact of such interventions on OS is unclear.
 <xref rid="R24" ref-type="bibr">24 55 56</xref>
</p>
